« Vaccine: Biomanufacturing and quality control testing challenges »

Save the date: the fourth edition of our webinar series will take place on 27^th May 2021! The team at Clean Biologics is setting up a thematic roundtable session focusing on challenges relating to biomanufacturing and quality control testing of viral vaccines, in association with Polepharma. Gäetan Blaize (Business Development Manager) will be hosting this meeting and will welcome Lucy Thulot (“Starting Material” expert), Ysaline Roland (“Biomanufacturing” expert) and Marc Meichenin (Scientific Director and “Quality Control” expert).

Our biopharmaceutical group, an expert in biological products, offers a window into our services and technologies, designed to support the development, manufacture and quality control testing of vaccines in compliance with applicable regulatory guidelines.

In the wake of the Covid-19 crisis and in anticipation of potential new pandemic events, Clean Cells and Naobios (companies of the Clean Biologics group) bring solutions to push innovative therapies with increased flexibility and expertise.

Please note that this roundtable session will only be held in French.

Gaëtan BLAIZE holds a PhD in Immunology and a Master’s degree in Management of the Pharmaceutical Industry. He accumulated 3 years of experience working for contractors of the biopharmaceutical industry. In August 2020, following two years as Business & Project Manager at the Biologics CDMO department of the Pierre Fabre group, he joined Clean Biologics as Business Development Manager to support the group development in France and Belgium.

Ysaline ROLAND holds a Biotechnology Engineering degree and benefits from 10 years of experience in development and implementation of viral vaccine manufacturing processes. She joined Naobios in 2009 as Bioprocess Engineer and then moved to a Head of Downstream Processing (DSP) position. She manages the GMP manufacturing activities relating to viral bulk harvests for clinical application.

Lucy THULOT accumulated more than 15 years of experience at Clean Cells during which she mastered a great set of cell and virus manufacturing methods. She started as Quality Control Technician and soon became Virology Technical Point of Contact. Following the creation of the Manufacturing department, she quickly moved to a position of Manufacturing Manager and soon took the lead of the department. Since 2019, she manages the manufactuging activities relating to starting material (cell and virus banks) further used in biopharmaceutical processes.

Marc MEICHENIN holds a PhD in Health and Life Sciences. In 2000, he creates Clean Cells, together with Olivier Boisteau and Frédéric a contract organization specializing in viral safety testing. He oervsaw the assay development and validation activities, a central part of the company’s business which has further proved to be a key element of Clean Cells’ international recognition. He holds the Chief Scientific Officer (CSO) position since the creation of the Clean Biologics group (gathering companies Clean Cells and Naobios) where he brings his technical and regulatory expertise.

We look forward to seeing you next 27th May at 11AM!
Follow the link to register to the event: https://bit.ly/32YU8xU

Meet the Clean Biologics’ team at :

• BIOMED ISRAËL : May 11-13, 2021
• BIO CONVENTION : June 10-11 & 14-18, 2021
• POLEPHARMA – Salon de la Bioproduction : June 17-18, 2021